@Ajit_Mohanty, @Ghonarbochon Hi Guys I am new to this platform. I had a query can you please let me know where can I find the expected Q4 or H2 FY24 result date of Droneacharya Aerial Innovations Ltd.? Searched the internet, cant seem to find it anywhere.

Hello, Sanghvi is different from Ace. Sanghvi is more of a distributor of Chinese equipment into India primarily catering to the wind sector. On the other hand, Ace has their own brand of cranes which has gained traction due to the infrastructure push. Ace is also manufacturing higher tonnage cranes now. Ace is making backhoe loaders which so far has been dominated by JCB and they intend to gain market share here. They also want to export these backhoe loaders. Also the return profile of Ace and Sanghvi is very different. Sanghvi has operated on low RoE in the past and also debt however Ace is comfortably 20%+ RoE and even higher RoCE and a net cash balance sheet.

HAL published its FY24 Results today – a good set of numbers in line with expectations .

Revenue during the year jumped 13% to Rs 30,381 crore. The same stood at Rs 26,927 crore a year ago. It’s consolidated net profit increased 31% to Rs 7,621 crore crore as compared to Rs 5,828 crore of FY23.

Importantly, margins during the March quarter improved to 35 % as against 25.9 % a year ago.

Execution continues to remain a key parameter.

Caplin Point continues to be a consistent performer with Q4 results.

Summary of q4 concall:

Caplin Point Laboratories reported a 15.5% YoY revenue growth and a 22.4% YoY increase in profit after tax. Contribution margins improved by approximately 3%

Caplin Steriles achieved over 50% revenue growth in the US-focused regulated market business, contributing 75% of product revenue.

Challenges in attracting the right talent have led to some delays in completing API projects. The company is also exploring direct sales to hospitals and clinics in the US market and actively seeking acquisition opportunities.

Results